Valuation: Virbac

Market Cap 300.06Cr 336.17Cr 276.11Cr 250.6Cr 474.91Cr 32TCr 486.7Cr 3.3TCr 1.32TCr 17TCr 1.26TCr 1.23TCr 53TCr P/E 2026 *
17.3x
P/E 2027 * 15.6x
Enterprise Value 310.89Cr 348.29Cr 286.07Cr 259.64Cr 492.05Cr 33TCr 504.26Cr 3.42TCr 1.36TCr 17TCr 1.31TCr 1.28TCr 55TCr EV / Sales 2026 *
2x
EV / Sales 2027 * 1.86x
Free-Float
49.03%
Yield 2026 *
0.47%
Yield 2027 * 0.53%
1 day-0.28%
1 week+0.71%
Current month+2.88%
1 month+12.62%
3 months+6.89%
6 months+1.42%
Current year-0.14%
1 week 347
Extreme 347
366
1 month 316
Extreme 316
366
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 249.7
Extreme 249.7
400
5 years 215
Extreme 215
446.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%+0.71%+3.33%+30.77% 336.17Cr
+4.28%+0.07%+52.75%+138.78% 1,25800Cr
+2.13%+4.27%+51.21%+91.36% 68TCr
+0.68%+1.54%+33.83%+112.47% 52TCr
-0.36%+2.05%+43.06%+68.53% 39TCr
+1.38%+0.27%+72.42%+45.30% 37TCr
+0.36%+1.95%+31.17%+59.86% 31TCr
-0.55%+1.74%+6.66%+38.75% 29TCr
+1.04%-0.05%+45.29%+76.18% 25TCr
+1.46%-0.59%+42.48%+125.82% 21TCr
Average +0.38%+1.06%+38.22%+78.78% 43TCr
Weighted average by Cap. +0.47%+1.18%+45.33%+96.72%

Financials

2026 *2027 *
Net sales 155.51Cr 174.23Cr 143.1Cr 129.88Cr 246.13Cr 16TCr 252.24Cr 1.71TCr 682.31Cr 8.74TCr 653.94Cr 639.95Cr 28TCr 165.09Cr 184.96Cr 151.91Cr 137.87Cr 261.29Cr 17TCr 267.78Cr 1.82TCr 724.32Cr 9.28TCr 694.21Cr 679.36Cr 29TCr
Net income 17Cr 19Cr 16Cr 14Cr 27Cr 1.82TCr 28Cr 190.61Cr 76Cr 973.48Cr 73Cr 71Cr 3.07TCr 19Cr 22Cr 18Cr 16Cr 31Cr 2.03TCr 31Cr 212.3Cr 85Cr 1.08TCr 81Cr 79Cr 3.42TCr
Net Debt 11Cr 12Cr 9.96Cr 9.04Cr 17Cr 1.14TCr 18Cr 119.16Cr 47Cr 608.58Cr 46Cr 45Cr 1.92TCr 6.42Cr 7.19Cr 5.91Cr 5.36Cr 10Cr 674.17Cr 10Cr 71Cr 28Cr 360.93Cr 27Cr 26Cr 1.14TCr
Projected Income Statement - Annual - Virbac
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
10/26/10 €357.00 -0.28% 250
09/26/09 €358.00 -0.42% 3,067
06/26/06 €359.50 0.00% 3,366
05/26/05 €359.50 -0.14% 11,244
04/26/04 €360.00 +1.55% 6,630
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Virbac
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
358.00EUR
Average target price
412.29EUR
Spread / Average Target
+15.16%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Virbac
  1. Stock Market
  2. Stocks
  3. VIRP Stock